NYSE:MET - Metlife Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $48.79 +0.37 (+0.76 %) (As of 09/23/2018 04:00 PM ET)Previous Close$48.79Today's Range$48.23 - $48.9252-Week Range$43.09 - $55.91Volume10.26 million shsAverage Volume4.13 million shsMarket Capitalization$48.54 billionP/E Ratio10.84Dividend Yield3.44%Beta1.22 Company ProfileDiscussionAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York. Receive MET News and Ratings via Email Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Life insurance Sub-IndustryLife & Health Insurance SectorFinance SymbolNYSE:MET CUSIP59156R10 Webwww.metlife.com Phone212-578-9500 Debt Debt-to-Equity Ratio0.29 Current Ratio0.15 Quick Ratio0.15 Price-To-Earnings Trailing P/E Ratio10.84 Forward P/E Ratio9.35 P/E Growth0.74 Sales & Book Value Annual Sales$62.09 billion Price / Sales0.78 Cash Flow$4.4761 per share Price / Cash10.90 Book Value$55.94 per share Price / Book0.87 Profitability EPS (Most Recent Fiscal Year)$4.50 Net Income$4.01 billion Net Margins6.12% Return on Equity9.17% Return on Assets0.73% Miscellaneous Employees49,000 Outstanding Shares994,840,000Market Cap$48.54 billion Metlife (NYSE:MET) Frequently Asked Questions What is Metlife's stock symbol? Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET." How often does Metlife pay dividends? What is the dividend yield for Metlife? Metlife declared a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.44%. The ex-dividend date is Friday, August 3rd. View Metlife's Dividend History. How will Metlife's stock buyback program work? Metlife declared that its Board of Directors has authorized a stock buyback plan on Tuesday, May 22nd 2018, which authorizes the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board of directors believes its shares are undervalued. How were Metlife's earnings last quarter? Metlife Inc (NYSE:MET) issued its quarterly earnings results on Wednesday, August, 1st. The financial services provider reported $1.30 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.17 by $0.13. The financial services provider had revenue of $21.22 billion for the quarter, compared to the consensus estimate of $15.65 billion. Metlife had a net margin of 6.12% and a return on equity of 9.17%. Metlife's revenue for the quarter was up 36.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.04 earnings per share. View Metlife's Earnings History. When is Metlife's next earnings date? Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Metlife. What price target have analysts set for MET? 15 analysts have issued 12-month target prices for Metlife's shares. Their forecasts range from $48.00 to $63.00. On average, they expect Metlife's stock price to reach $55.00 in the next twelve months. This suggests a possible upside of 12.7% from the stock's current price. View Analyst Price Targets for Metlife. What is the consensus analysts' recommendation for Metlife? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 8 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife. What are Wall Street analysts saying about Metlife stock? Here are some recent quotes from research analysts about Metlife stock: 1. According to Zacks Investment Research, "MetLife’s shares have outperformed its industry’s gain quarter to date. Moreover, the company has witnessed its 2018 and 2019 estimates move upward over the last 30 days. The company has been significantly performing well on the back of prudent underwriting and expense management. Its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 and first half of 2018 after declining for two years and the trend is likely to continue. Its strong international operations and disciplined capital management should drive long-term growth. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins." (9/3/2018) 2. Wells Fargo & Co analysts commented, "We hosted investor meetings with MetLife today (March 15) at the company’s NYC headquarters. From MET were Steven Kandarian, President, Chairman & CEO; John Hele, EVP & CFO; and John Hall, SVP & Head of IR. Investors were focused on MET’s material weaknesses (MW), unit cost initiative (UCI), long term care reserves, Brighthouse exchange offer, and reinsurance opportunities with MetLife Holdings. To us, the investment case for MET remains unchanged – faster growth in less capital intensive and less volatile businesses should lower the company’s cost of equity, which in turn should allow MetLife to achieve a higher ROE spread as well as a higher valuation multiple. We reiterate our Outperform rating on MET, which is also our top pick." (3/16/2018) Who are some of Metlife's key competitors? Some companies that are related to Metlife include AXA (AXAHY), China Life Insurance (LFC), Prudential Public (PUK), Prudential Financial (PRU), Manulife Financial (MFC), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG), Athene (ATH) and Torchmark (TMK). Who are Metlife's key executives? Metlife's management team includes the folowing people: Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)Mr. Martin J. Lippert, Exec. VP and Head of Global Technology & Operations (Age 58)Mr. Steven Jeffery Goulart, Exec. VP & Chief Investment Officer (Age 59)Mr. Michel A. Khalaf, Pres of U.S. Bus. & EMEA (Age 54)Mr. John Carroll Ramsey Hele, Sr. Adviser (Age 60) Who are Metlife's major shareholders? Metlife's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.11%), FMR LLC (4.70%), Massachusetts Financial Services Co. MA (2.41%), Bank of New York Mellon Corp (1.28%), Bank of New York Mellon Corp (1.31%) and Northern Trust Corp (1.08%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris, Peter M Carlson and Steven A Kandarian. View Institutional Ownership Trends for Metlife. Which institutional investors are selling Metlife stock? MET stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Epoch Investment Partners Inc., BlackRock Inc., Canada Pension Plan Investment Board, Bank of Montreal Can, Jennison Associates LLC, Caisse DE Depot ET Placement DU Quebec and United Services Automobile Association. Company insiders that have sold Metlife company stock in the last year include Christopher G Townsend and Steven A Kandarian. View Insider Buying and Selling for Metlife. Which institutional investors are buying Metlife stock? MET stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Pzena Investment Management LLC, Morgan Stanley, Robeco Institutional Asset Management B.V., Royal London Asset Management Ltd., Putnam Investments LLC, Sumitomo Mitsui Trust Holdings Inc. and LSV Asset Management. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife. How do I buy shares of Metlife? Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Metlife's stock price today? One share of MET stock can currently be purchased for approximately $48.79. How big of a company is Metlife? Metlife has a market capitalization of $48.54 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe. What is Metlife's official website? The official website for Metlife is http://www.metlife.com. How can I contact Metlife? Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500. MarketBeat Community Rating for Metlife (NYSE MET)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 727 (Vote Outperform)Underperform Votes: 444 (Vote Underperform)Total Votes: 1,171MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/23/2018 by MarketBeat.com StaffFeatured Article: Why is the ex-dividend date different from the record date?